G13R HRAS

Stable Identifier
R-HSA-6802368
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
External Reference Information
External Reference
Gene Names
HRAS, HRAS1
Chain
initiator methionine:1, chain:1-186, chain:2-186, propeptide:187-189
Other Identifiers
0002640458
0006900092
11733320_a_at
11744709_a_at
121P
1590_s_at
16733952
1AA9
1AGP
1BKD
1CLU
1CRP
1CRQ
1CRR
1CTQ
1GNP
1GNQ
1GNR
1HE8
1IAQ
1IOZ
1JAH
1JAI
1K8R
1LF0
1LF5
1LFD
1NVU
1NVV
1NVW
1NVX
1P2S
1P2T
1P2U
1P2V
1PLJ
1PLK
1PLL
1Q21
1QRA
1RVD
1WQ1
1XCM
1XD2
1XJ0
1ZVQ
1ZW6
2015
212983_at
221P
2C5L
2CE2
2CL0
2CL6
2CL7
2CLC
2CLD
2EVW
2GDP
2LCF
2LWI
2N42
2N46
2Q21
2QUZ
2RGA
2RGB
2RGC
2RGD
2RGE
2RGG
2UZI
2VH5
2X1V
3265
3358091
3358092
3358093
3358094
3358096
3358097
3358098
3358099
3358100
3358103
35701_at
3DDC
3I3S
3K8Y
3K9L
3K9N
3KKM
3KKN
3KUD
3L8Y
3L8Z
3LBH
3LBI
3LBN
3LO5
3OIU
3OIV
3OIW
3RRY
3RRZ
3RS0
3RS2
3RS3
3RS4
3RS5
3RS7
3RSL
3RSO
3TGP
421P
49830
4DLR
4DLS
4DLT
4DLU
4DLV
4DLW
4DLX
4DLY
4DLZ
4DST
4DSU
4EFL
4EFM
4EFN
4G0N
4G3X
4K81
4L9S
4L9W
4NYI
4NYJ
4NYM
4Q21
4RSG
4URU
4URV
4URW
4URX
4URY
4URZ
4US0
4US1
4US2
4XVQ
4XVR
521P
5B2Z
5B30
5E95
5P21
5VBE
5VBZ
5WDO
5WDP
5WDQ
5WPL
5X9S
621P
6AMB
6AXG
6Q21
721P
7945436
821P
A_23_P98183
AAA35685
AAB02605
AAH06499
AAH95471
AAM12630
AAV38228
AB451336
AB451485
ABI97389
AF493916
AHW56507
AHW56508
AJ437024
BAG70150
BAG70299
BC006499
BC095471
BT019421
CAB002015
CAD24594
CAG38816
CAG47067
CCDS7698
CCDS7699
CH471158
CR536579
CR542271
EAX02337
EAX02338
EAX02339
EAX02340
EAX02341
EF015887
ENSG00000174775
ENSG00000276536
ENSP00000309845
ENSP00000380722
ENSP00000380723
ENSP00000388246
ENSP00000407586
ENSP00000434023
ENSP00000480317
ENSP00000480686
ENSP00000482366
ENSP00000488225
ENSP00000488296
ENSP00000488757
ENST00000311189
ENST00000397594
ENST00000397596
ENST00000417302
ENST00000451590
ENST00000493230
ENST00000610977
ENST00000615062
ENST00000616241
ENST00000631404
ENST00000631967
ENST00000634098
EntrezGene:3265
GE57461
GO:0000139
GO:0000165
GO:0000166
GO:0000278
GO:0001934
GO:0002223
GO:0002376
GO:0003674
GO:0003924
GO:0005515
GO:0005525
GO:0005575
GO:0005622
GO:0005623
GO:0005634
GO:0005737
GO:0005794
GO:0005829
GO:0005886
GO:0006259
GO:0006464
GO:0006605
GO:0006810
GO:0006897
GO:0006915
GO:0006935
GO:0006950
GO:0007010
GO:0007049
GO:0007050
GO:0007093
GO:0007165
GO:0007166
GO:0007264
GO:0007265
GO:0007267
GO:0007568
GO:0007569
GO:0008022
GO:0008150
GO:0008219
GO:0008283
GO:0008284
GO:0008285
GO:0009058
GO:0009887
GO:0010628
GO:0010629
GO:0010863
GO:0016020
GO:0016192
GO:0019003
GO:0022607
GO:0030335
GO:0032729
GO:0034260
GO:0034641
GO:0035900
GO:0040011
GO:0042088
GO:0042832
GO:0043167
GO:0043226
GO:0043231
GO:0043406
GO:0043410
GO:0043524
GO:0043547
GO:0045740
GO:0045944
GO:0046330
GO:0046579
GO:0048013
GO:0048169
GO:0048471
GO:0048856
GO:0048870
GO:0050679
GO:0050852
GO:0051291
GO:0065003
GO:0070374
GO:0071480
GO:0090303
GO:0090314
GO:0090398
GO:0097193
GO:1900029
GO:2000251
GO:2000630
HGNC:5173
HPA049830
HRAS
HRAS-201
HRAS-202
HRAS-203
HRAS-204
HRAS-205
HRAS-211
HRAS-212
HRAS-213
HRAS-214
HRAS-215
HRAS-217
HRAS-222
Hs.37003.0.S1_3p_at
Hs.37003.0.S1_3p_x_at
ILMN_1699798
ILMN_1773751
IPR001806
IPR005225
IPR020849
IPR027417
J00277
J00277_at
KJ534867
KJ534868
M17232
MIM:109800
MIM:137550
MIM:162900
MIM:163200
MIM:188470
MIM:190020
MIM:218040
NM_001130442
NM_001318054
NM_005343
NM_176795
NP_001123914
NP_001304983
NP_005334
NP_789765
PF00071
PH_hs_0031161
PR00449
SM00173
SM00174
SM00175
TC11001236.hg
uc001lpv.4
uc010qvw.3
uc010qvx.3
uc057xhs.1
uc057xht.1
uc057xhu.1
UPI0000001251
UPI000000DCA4
V00574_s_at
X5D945
Participant Of
Other forms of this molecule
Modified Residues
Name
glycine 13 replaced with L-arginine
Coordinate
13
PsiMod HEY
A protein modification that effectively converts a source amino acid residue to an L-arginine.
A protein modification that effectively removes or replaces an glycine.
Disease
Name Identifier Synonyms
melanoma 1909 Naevocarcinoma, melanoma, melanoma, malignant melanoma, morphology (morphologic abnormality), malignant melanoma NOS (morphologic abnormality), malignant melanoma (disorder), malignant melanoma, malignant melanoma, malignant melanoma, malignant melanoma
bladder carcinoma 4007 carcinoma of urinary bladder, carcinoma bladder, carcinoma OF BLADDER, carcinoma of bladder (disorder), carcinoma bladder
thyroid cancer 1781 Thyroid gland neoplasm, thyroid cancer, thyroid neoplasm, neoplasm of thyroid gland, thyroid neoplasm, Thyroid neoplasm, malignant tumour of thyroid gland, malignant neoplasm of thyroid gland
larynx cancer 2596
Interactors (10)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P04049 RAF1  11 0.975 25
 UniProt:Q07889 SOS1  3 0.938 11
 UniProt:P15056 BRAF  34 0.719 4
 UniProt:Q12967 RALGDS  1 0.704 3
 UniProt:Q9NZL6 RGL1  1 0.667 3
 UniProt:P42337 Pik3ca  1 0.589 3
 UniProt:Q9EQZ6  1 0.556 3
 ATP [ChEBI:15422]  12 0.544 2
 UniProt:Q7Z569 BRAP  2 0.524 3
 UniProt:Q03135 CAV1  5 0.508 2